Market Place
Sourcing Support
Bristol Myers Squibb to Report Q3 2025 Results on Oct 30, 2025
19 Sep 2025 //
BUSINESSWIRE
Novo, BMS Layoffs Leave Over 500 Jobless in New Jersey
18 Sep 2025 //
BIOSPACE
6 Pharma Layoffs Could Eliminate Over 39,000 Jobs
18 Sep 2025 //
BIOSPACE
Bristol Myers Squibb Announces Dividend
17 Sep 2025 //
BUSINESSWIRE
NJ layoffs: Novo Nordisk dismisses 263, BMS cuts 282 workers
17 Sep 2025 //
FIERCE PHARMA
FDA approves Lupin`s Lenalidomide capsules
17 Sep 2025 //
INDPHARMAPOST
J&J`s IL-23 Drug Defeats Sotyktu in Phase 3 Psoriasis Trial
17 Sep 2025 //
PR NEWSWIRE
FDA Issues Over 100 Warnings in Ad Crackdown
16 Sep 2025 //
RAPS
BMS Sells Majority Stake in Historic US-China Pharmaceutical JV
16 Sep 2025 //
FIERCE PHARMA
Biocartis NV Gets FDA Approval for Idylla™ CDx MSI Test
15 Sep 2025 //
GLOBENEWSWIRE
Novartis Falls in Another IRA Price Negotiation Loss for Pharma
12 Sep 2025 //
FIERCE PHARMA
BioNTech, BMS Tout First Global Data for Pd-L1x Vegf Bispecific
09 Sep 2025 //
PRESS RELEASE
Braveheart Pays $65 M to Challenge BMS for Heart Disease Market
05 Sep 2025 //
FIERCE BIOTECH
Bristol Myers Squibb Showcases Camzyos Real-World Results at ESC
29 Aug 2025 //
PHARMAWEB
Bristol Myers Squibb to Unveil Clinical Data at ESC Congress 2025
25 Aug 2025 //
PHARMAWEB
FDA Approves Agilent MMR IHC Panel for Colorectal Cancer
20 Aug 2025 //
BUSINESSWIRE
U.S. FDA grants Breakthrough Therapy for Izalontamab Brengitecan
18 Aug 2025 //
PR NEWSWIRE
BMS’ Breyanzi Accepted for Review in Marginal Zone Lymphoma
04 Aug 2025 //
BUSINESSWIRE
Bristol Myers Squibb`s Q2 2025 Financial Results Released
31 Jul 2025 //
BUSINESSWIRE
BMS Highlights Commercial Success Amid Clinical Setbacks
31 Jul 2025 //
FIERCE BIOTECH
BMS` Cobenfy Future Uncertain After Phase III Failure
31 Jul 2025 //
BIOSPACE
Bristol Myers, Bain form New Company to Develop Immunology Drug
29 Jul 2025 //
REUTERS
Bristol Myers Squibb Appoints New Evp, Chief Medical Officer
25 Jul 2025 //
CONTRACTPHARMA
BMS`s sNDA for Sotyktu in Psoriatic Arthritis Under Review
21 Jul 2025 //
BUSINESSWIRE
BMS` Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial
19 Jul 2025 //
BIOSPACE
BMS, Pfizer offer Eliquis to patients at 40% below list price
18 Jul 2025 //
FIERCE PHARMA
BioNTech`s Chief Strategy Officer Heads for The Exit
17 Jul 2025 //
FIERCE BIOTECH
BMS Opens RayzeBio Radiopharma Production Site in Indianapolis
15 Jul 2025 //
FIERCE PHARMA
Onco360 named national specialty pharmacy for Augtyro
07 Jul 2025 //
GLOBENEWSWIRE
Biokin, having landed BMS deal, posts ph. 3 Bispecific ADC win
03 Jul 2025 //
FIERCE BIOTECH
BMS`s Biologics Opdivo Receive Suppl Approval in US
01 Jul 2025 //
FDA
FDA Eliminates Risk Evaluation, Mitigation for Car-T Therapies
28 Jun 2025 //
REUTERS
FDA Updates Bristol Myers Squibb Cell Therapy Label, Removes REMS
26 Jun 2025 //
BUSINESSWIRE
Cigna Files Anti-Competition Lawsuit Against BMS Over Pomalyst
25 Jun 2025 //
FIERCE PHARMA
Bristol Myers Squibb Announces Dividend
17 Jun 2025 //
BUSINESSWIRE
Biogen, BMS and Novartis bag spots on Cannes Lions shortlists
16 Jun 2025 //
FIERCE PHARMA
BMS Taps Biotech Analyst to Lead Long-Term Strategy
13 Jun 2025 //
FIERCE BIOTECH
Bristol Myers Squibb to Report Q2 2025 Results on July 31, 2025
12 Jun 2025 //
BUSINESSWIRE
BMS Shows CELMoD BCL6 Degrader Data at EHA 2025
12 Jun 2025 //
BUSINESSWIRE
Bristol Myers CEO Stays Bullish on Cobenfy despite trial flop
12 Jun 2025 //
FIERCE PHARMA
BMS`s Deucravacitinib Shows Superiority in Psoriatic Arthritis
12 Jun 2025 //
BUSINESSWIRE
RayzeBio bags Philochem’s Cancer Radiotracer in $1.35B deal
11 Jun 2025 //
GLOBENEWSWIRE
FDA limits Merck`s Keytruda, BMS` Opdivo in Stomach Cancer
10 Jun 2025 //
FIERCE PHARMA
Markey Researchers Get $6.8M For Lung Cancer Screening Model
06 Jun 2025 //
ACCESSWIRE
ASCO: Bristol CMO brushes off LAG-3 concern after melanoma flop
03 Jun 2025 //
FIERCE PHARMA
Bristol Myers Squibb gets EU approval for Opdivo Subcutaneous
28 May 2025 //
BUSINESSWIRE
BMS to Join Goldman Sachs Global Healthcare Conference
28 May 2025 //
BUSINESSWIRE
BMS`s Biologics Yervoy Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Qvantig Receives Suppl Approval in US
23 May 2025 //
FDA
Bristol Myers Squibb to Present Data at ASCO® 2025
22 May 2025 //
BUSINESSWIRE
Bristol Myers Squibb at Bernstein 41st Annual Strategic Decisions
21 May 2025 //
BUSINESSWIRE
Tubulis Hits Milestone in BMS License as Tubutecan ADC
20 May 2025 //
GLOBENEWSWIRE
Breakthroughs in KRAS Inhibitor Scaffolds
16 May 2025 //
PRESS RELEASE
Bristol Myers gets EU approval for Opdivo regimen in lung Cancer
16 May 2025 //
BUSINESSWIRE
Hawaii settles for $700 million with Bristol-Myers, Sanofi
12 May 2025 //
REUTERS
BMS`s Augtyro Receives Approval in Canada
07 May 2025 //
HEALTH CANADA
Strengthening Local Health System Capacity for Better Care
07 May 2025 //
ACCESSWIRE
2seventy bio Reports Q1 Results, Update on BMS Acquisition
07 May 2025 //
BUSINESSWIRE
Bristol Myers Squibb Names Cari Gallman EVP, General Counsel & CPO
06 May 2025 //
BUSINESSWIRE
